期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性白血病药物基因组学研究现况 被引量：1

Research Update on Pharmacogenomics in Acute Leukemia——Review
暂未订购
导出
摘要 药物基因组学是一门旨在阐明药物疗效个体差异遗传学基础的新学科,根据这些遗传学信息来预测个体对某一药物的用药安全性和疗效,指导临床个体化治疗,从遗传学的角度为急性白血病的合理用药开辟了新的途径。本文对急性白血病治疗药物代谢、转运及作用靶点相关酶系编码基因的多态性与治疗不良反应及疾病预后之间关系的研究现况作一综述。 Pharmacogenomics, a new subject aiming to elucidate genetic basis for inter individual differences in response on a drug and to predict the safety and efficacy of drugs by the genetic information, which guides to clinical individual therapy, breaks a new way to apply drugs rationally to acute leukemia. This article reviewed the enzymes related to metabolism, transport and acting point of the drugs used in the treatment of acute leukemia and discussed the influence of their coding gene＇s polymorphism on drug adverse effects and disease prognosis.
作者 李璘 肖志坚
机构地区 中国医学科学院血液学研究所血液病医院；实验血液学国家重点实验室
出处 《中国实验血液学杂志》 CAS CSCD 2008年第3期704-711,共8页 Journal of Experimental Hematology
基金 新世纪优秀人才资助计划(编号NCET-05-0173) 863计划(编号2006AA02A405)资助
关键词 药物基因组学 基因多态性 白血病 pharmacogenomics genetic polymorphism leukemia
分类号 R733.71 [医药卫生—肿瘤]
  • 相关文献

参考文献44

  • 1Evans, WE. Thiopurine S-methyhransferase: a genetic polymorphism that affects a small number of drugs in a big way. Pharmacogenetics,2002 ; 12:421 -423.
  • 2Relling MV, Pui CH, Cheng C, et al. Thiopufine methyltransferase in acute lymphoblastic leukemia. Blood, 2006 ; 107:843 - 844.
  • 3Stanulla M, Schaeffeler E, Flohr T, et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA, 2005 ; 293 : 1485 - 1489.
  • 4Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive arialysis of thiopufine S-methyhransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics, 2004 ; 14 : 407 - 417.
  • 5Chiusolo P, Reddiconto G, Casorelli I,et al. Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate. Ann Oncol, 2002 ; 13 : 1915 - 1918.
  • 6Costea I, Moghrabi A, Laverdiere C ,et al. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia. Haematologica ,2006 ;91 : 1113 - 1116.
  • 7Aplenc R, Thompson J, Hart P, et al. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res,2005 ;65:2482 -2487.
  • 8Krajitaovic M, Lemieux-Blanchard E, Chiasson S, et al. Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukaemia. Pharmacogenomics J, 2004 ; 4 : 66 - 72.
  • 9de-Jonge R, Hooijberg JH, van-Zelst BD,et al. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood ,2005 ; 106:717 - 720.
  • 10王汉平,谢健晋,张泽云,应逸,朱志刚,毛平.CYP3A5基因的多态性及其临床意义的研究[J].中华医学遗传学杂志,2005,22(4):423-426. 被引量：9

二级参考文献24

  • 1杨琳,张悦,张美荣,肖志坚.GSTT1,GSTM1和NQO1基因多态性与急性髓系白血病发生及其重现染色体异常关系的研究[J].中华医学杂志,2005,85(33):2312-2316. 被引量：4
  • 2Koch I, Weil R, Wolbold R, et al. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos, 2002, 30∶1108-1114.
  • 3Tateishi T, Watanabe M, Moriya H, et al. No ethnic differences between Caucasian and Japanese samples in the expression frequency of CYP3A5 and CYP3A7 proteins. Biochem Pharmacol, 1999, 57∶935-939.
  • 4Huang W, Lin YS, McConn DJ, et al. Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. Drug Metab Dispos, 2004, 32∶1434-1445.
  • 5Kuehl P, Zhang J, Lin Y, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet, 2001, 27∶383-391.
  • 6Lin YS, Dowling AL, Quigley SD, et al. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol, 2002, 62∶162-172.
  • 7Hustert E, Haberl M, Burk O, et al. The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics, 2001, 11∶773-779.
  • 8Zhu B, Chen GL, Chen XP, et al. Genotype of CYP3AP1 associated with CYP3A activity in Chinese Han population. Acta Pharmacol Sin, 2002, 23∶567-571.
  • 9Yates CR, Zhang W, Song P, et al. Effect of CYP3A5 genotype on cyclosporine disposition: a pilot study. Clin Pharmacol Ther, 2002, 71∶P2.
  • 10Dai Y, Iwanaga K, Lin YS, et al. In vitro metabolism of cyclosporine A by human kidney CYP3A5. Biochem Pharmacol, 2004, 68∶1889-1902.

共引文献29

同被引文献15

  • 1Pui CH, Mullighan CG, Evans WE, et al. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood, 2012, 120(6) :1165 - 1174.
  • 2Liu SG, Li ZG, Cui L, et al. Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population. Leuk Lymphoma, 2011 , 52 (6) :1030 - 1040.
  • 3Leclerc GJ, Mou C, Leclerc GM, et al. Histone deacetylase inhibitors induce FlaGS mRNA expression and intracellular accu- mulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy. Leukemia, 2010 , 24 ( 3 ) :552 - 562.
  • 4Rots MG, Willey JC, Jansen G, et al. mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method. Leukemia, 2000, 14(12): 2166-2175.
  • 5van der Straaten RJ, Wessels JA, de Vries-Bouwstra JK, et al. Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients. Pharmacogenomics, 2007 , 8 (2) : 141 - 150.
  • 6Sharma S, Das M, Kumar A, et al. Interaction of genes from influx-metabolism-efflux pathway and their influence on metho- trexate efficacy in rheumatoid arthritis patients among Indians. Pharmacogenet Genomics, 2008 , 18(12) :1041 - 1049.
  • 7Sharma S, Das M, Kumar A, Marwaha V, et al. Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians. Pharmacogenet Genomics, 2009 , 19 (10) : 823 - 828.
  • 8Ranganathan P, Culverhouse R, Marsh S, et al. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol, 2008 , 35 (4) :572 - 579.
  • 9Yanagimachi M, Naruto T, Ham T, et al. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Br J Clin Pharmacol, 2011 , 71 (2) :237 -243.
  • 10Liu SG, Gao C, Zhang RD, et al. FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Cancer Cell Int, 2013 , 13 ( 1 ) : 107.

引证文献1

二级引证文献2

中国实验血液学杂志
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部